These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Lainscak M; Hodoscek LM; Düngen HD; Rauchhaus M; Doehner W; Anker SD; von Haehling S Wien Klin Wochenschr; 2009; 121(9-10):309-13. PubMed ID: 19562292 [TBL] [Abstract][Full Text] [Related]
13. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF). Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803 [TBL] [Abstract][Full Text] [Related]
14. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry. Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY; Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697 [TBL] [Abstract][Full Text] [Related]
15. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative. Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703 [TBL] [Abstract][Full Text] [Related]
16. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study. Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921 [TBL] [Abstract][Full Text] [Related]
17. Female gender and mortality risk in decompensated heart failure. Scrutinio D; Guida P; Passantino A; Lagioia R; Raimondo R; Venezia M; Ammirati E; Oliva F; Stucchi M; Frigerio M Eur J Intern Med; 2018 May; 51():34-40. PubMed ID: 29317139 [TBL] [Abstract][Full Text] [Related]
19. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure. Katz A; Maor E; Leor J; Klempfner R Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675 [TBL] [Abstract][Full Text] [Related]
20. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ; PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]